As a result, knock down of Fas or DR3 partially reversed the inhibitory effect of (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol on colon cancer cells but not knock down of DR4 or DR5 (Figure 2D). Here, TNFRSF25 is linked to colonic neoplasm.